Treatment for metastatic nasopharyngeal carcinoma

European Annals of Otorhinolaryngology, Head and Neck Diseases

Volumn 128, Issue 2, 2011, Pages 79-85

  Bensouda, Y ^a   Kaikani, W ^a   Ahbeddou, N ^a   Rahhali, R ^a   Jabri, M ^b   Mrabti, H ^a   Boussen, H ^c   Errihani, H ^a  

^a MOHAMMED V UNIVERSITY   (Morocco)

^b IBN SINA HOSPITAL   (Morocco)

^c SALAH AZAIEZ INSTITUTE   (Tunisia)

Author keywords

Chemotherapy; Metastatic; Nasopharyngeal carcinoma; Targeted therapy

Indexed keywords

4 EPIDOXORUBICINE; ANTHRACYCLINE; BISPHOSPHONIC ACID DERIVATIVE; BLEOMYCIN; CAPECITABINE; CARBOPLATIN; CETUXIMAB; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIRUBICIN; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; IFOSFAMIDE; IRINOTECAN; MITOXANTRONE; NAVELBINE; OXALIPLATIN; PACLITAXEL; SORAFENIB; UNCLASSIFIED DRUG;

ANEMIA; BONE MARROW TOXICITY; BONE METASTASIS; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CONTINUOUS INFUSION; DRUG EFFICACY; DRUG FATALITY; FEBRILE NEUTROPENIA; GENE OVEREXPRESSION; HEAD AND NECK CARCINOMA; HUMAN; LUNG METASTASIS; METASTASIS; MONOTHERAPY; MUCOSA INFLAMMATION; NASOPHARYNX CARCINOMA; NEUTROPENIA; ONCOGENE C KIT; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL (TOPIC); PROGNOSIS; PROGRESSION FREE SURVIVAL; QUALITY OF LIFE; REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 79955479303     PISSN: 18797296     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anorl.2010.10.003     Document Type: Short Survey

References (55)

1. C.S. Muir, J. Waterhouse, and T. Mack Cancer incidence in five continents. Classification IARC Sci Publ 120 1992 25 30
2. A.W.M. Lee, Y.F. Poon, and W. Foo Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure Int J Radiat Oncol Biol Phys 23 1992 261 270
3. A. Fandi, M. Bachouchi, and N. Azli Long-term disease-free survivors in metastatic undifferentiated carcinoma of the nasopharyngeal type J Clin Oncol 18 2000 1324 1330 (Pubitemid 30159852)
4. T. Liu, W. Xu, W.L. Yan, M. Ye, Y.R. Bai, and G. Huang MRI for diagnosis of local residual or recurrent nasopharyngeal carcinoma, which one is the best? A systematic review Radiother Oncol 85 2007 327 335 (Pubitemid 350213149)
5. K.W. Fong, E.J. Chua, and E.T. Chua Patient profile and survival in 270 computer tomography-staged patients with nasopharyngeal cancer treated at the Singapore general hospital Ann Acad Med Singapore 25 1996 341 346 (Pubitemid 126496620)
6. C.A. Perez, V.R. Devineni, V. Marcial-Vega, J.E. Marks, J.R. Simpson, and N. Kucik Carcinoma of the nasopharynx: factors affecting prognosis Int J Radiat Oncol Biol Phys 23 1992 271 280
7. P.M. Teo, W.H. Kwan, W.Y. Lee, S.F. Leung, and P.J. Johnson Prognostic factors determining survival subsequent to distant metastasis from nasopharyngeal carcinoma Cancer 77 1996 2423 2431 (Pubitemid 26169137)
8. A. Ahmad, and S. Stefani Distant metastases of nasopharyngeal carcinoma. A study of 256 male patients J Surg Oncol 33 1986 194 197 (Pubitemid 17188823)
9. Y.K. Ong, D.M. Heng, and B. Chung Design of a prognostic index score for metastatic nasopharyngeal carcinoma Eur J Cancer 39 2003 1535 1541 (Pubitemid 36829194)
10. B.B. Ma, and A.T. Chan Recent perspectives in the role of chemotherapy in the management of advanced nasopharyngeal carcinoma Cancer 103 2005 22 31 (Pubitemid 39665453)
11. W.C.T. Shiu, and S.Y. Tsao Efficacy of 4′-epidoxorubicin in advanced nasopharyngeal carcinoma Clin Trials J 26 1989 419
12. M. Dugan, D. Choy, and A. Ngai Multicenter phase II trial of mitoxantrone in patients with advanced nasopharyngeal carcinoma in Southeast Asia: an Asian-Oceanian Clinical Oncology Association Group Study J Clin Oncol 11 1993 70 76 (Pubitemid 23059977)
13. E. Au, E.H. Tan, and P.T. Ang Activity of paclitaxel by three-hour infusion in Asian patients with metastatic undifferentiated nasopharyngeal cancer Ann Oncol 9 1998 327 329 (Pubitemid 28186804)
14. D. Poon, B. Chowbay, Y.B. Cheung, S.S. Leong, and E.H. Tan Phase II study of irinotecan (CPT-11) as salvage therapy for advanced nasopharyngeal carcinoma Cancer 103 2005 576 581
15. K.F. Foo, E.H. Tan, and S.S. Leong Gemcitabine in metastatic nasopharyngeal carcinoma of the undifferentiated type Ann Oncol 13 2002 150 156
16. B.B. Ma, I.F. Tannock, G.R. Pond, M.R. Edmonds, and L.L. Siu Chemotherapy with gemcitabine-containing regimens for locally recurrent or metastatic nasopharyngeal carcinoma Cancer 95 2002 2516 2523 (Pubitemid 35424037)
17. D.T. Chua, J.S. Sham, and G.K. Au A phase II study of capecitabine in patients with recurrent and metastatic nasopharyngeal carcinoma pretreated with platinum-based chemotherapy Oral Oncol 39 2003 36
18. D. Chua, W.I. Wei, and J.S. Sham Capecitabine monotherapy for recurrent and metastatic nasopharyngeal cancer Jpn J Clin Oncol 38 2008 244 249 (Pubitemid 351583987)
19. E. Ciuleanu, A. Irimie, T.E. Ciuleanu, V. Popita, N. Todor, and N. Ghilezan Capecitabine as salvage treatment in relapsed nasopharyngeal carcinoma: a phase II study J BUON 13 2008 37 42 (Pubitemid 351460874)
20. L. Zhang, Y. Zhang, P.Y. Huang, F. Xu, P.J. Peng, and Z.Z. Guan Phase II clinical study of gemcitabine in the treatment of patients with advanced nasopharyngeal carcinoma after the failure of platinum-based chemotherapy Cancer Chemother Pharmacol 61 2008 33 38 PMID: 20716628 (Pubitemid 47512623)
21. J. Ngeow, W.T. Lim, and S. Leong Docetaxel is effective in heavily pretreated patients with disseminated nasopharyngeal carcinoma Ann Oncol 2010 [Epub ahead of print], PMID: 20716628 http://www.ncbi.nlm.nih.gov/pubmed/ 20716628
22. T.L. Wang, and Y.O. Tan Cisplatin and 5-fluorouracil continuous infusion for metastatic nasopharyngeal carcinoma Ann Acad Med Singapore 20 1991 601 603
23. E. Au, and P.T. Ang A phase II trial of 5-fluorouracil and cisplatinum in recurrent or metastatic nasopharyngeal carcinoma Ann Oncol 5 1994 87 89 (Pubitemid 24049859)
24. K.H. Chi, W.K. Chan, and D.L. Cooper A phase II study of outpatient chemotherapy with cisplatin, 5-uorouracil and leucovorin in nasopharyngeal carcinoma Cancer 73 1994 247 252 (Pubitemid 24030597)
25. M.E. Stein, P. Ruff, A. Weaving, J. Fried, and W.R. Bezwoda A phase II study of cisplatin/ifosfamide in recurrent/metastatic undifferentiated nasopharyngeal carcinoma among young blacks in southern Africa Am J Clin Oncol 19 1996 386 388 (Pubitemid 26242238)
26. W. Yeo, T.W. Leung, S.F. Leung, P.M. Teo, A.T. Chan, and W.Y. Lee Phase II study of the combination of carboplatin and 5-fluorouracil in metastatic nasopharyngeal carcinoma Cancer Chemother Pharmacol 38 1996 466 470 (Pubitemid 26281085)
27. W. Yeo, T.W. Leung, and A.T. Chan A phase II study combination of paclitaxel and carboplatin in advanced nasopharyngeal carcinoma Eur J Cancer 34 1998 2027 2031 (Pubitemid 28546936)
28. E.H. Tan, K.S. Khoo, and J. Wee Phase II trial of a paclitaxel and carboplatin combination in Asian patients with metastatic nasopharyngeal carcinoma Ann Oncol 10 1999 235 237 (Pubitemid 29113186)
29. T.E. Ciuleanu, G. Fountzilas, E. Ciuleanu, M. Plataniotis, N. Todor, and N. Ghilezan Paclitaxel and carboplatin in relapsed or metastatic nasopharyngeal carcinoma: a multicenter phase II study J BUON 9 2004 161 165 (Pubitemid 39149458)
30. R.K. Ngan, H.H. Yiu, and W.H. Lau Combination gemcitabine and cisplatin chemotherapy for metastatic or recurrent nasopharyngeal carcinoma: report of a phase II study Ann Oncol 13 2002 1252 1258 (Pubitemid 34960134)
31. J. Wang, J. Li, X. Hong, W. Tang, X. Hu, and B. Wang Retrospective case series of gemcitabine plus cisplatin in the treatment of recurrent and metastatic nasopharyngeal carcinoma Oral Oncol 44 2008 464 470 (Pubitemid 351608616)
32. B.B. Ma, E.P. Hui, and S.C. Wong Multicenter phase II study of gemcitabine and oxaliplatin in advanced nasopharyngeal carcinoma - correlation with excision repair cross-complementing-1 polymorphisms Ann Oncol 20 2009 1854 1859 [Epub 2009 Jun 23]
33. J.S. McCarthy, I.F. Tannock, P. Degendorfer, T. Panzarella, M. Furlan, and L.L. Siu A Phase II trial of docetaxel and cisplatin in patients with recurrent or metastatic nasopharyngeal carcinoma Oral Oncol 38 2002 686 690 PMID: 12167421 (Pubitemid 34880107)
34. D.T. Chua, J.S. Sham, and G.K. Au A phase II study of docetaxel and cisplatin as first-line chemotherapy in patients with metastatic nasopharyngeal carcinoma Oral Oncol 41 2005 589 595 (Pubitemid 40828875)
35. Y.H. Li, F.H. Wang, and W.Q. Jiang Phase II study of capecitabine and cisplatin combination as first-line chemotherapy in Chinese patients with metastatic nasopharyngeal carcinoma Cancer Chemother Pharmacol 62 2008 539 544 [Epub 2008 Jan]
36. D.T. Chua, D.L. Kwong, J.S. Sham, G.K. Au, and D. Choy A phase II study of ifosfamide, 5-fluorouracil and leucovorin in patients with recurrent nasopharyngeal carcinoma previously treated with platinum chemotherapy Eur J Cancer 36 2000 736 741 PMID: 10762745 (Pubitemid 30179744)
37. H.Q. Huang, Z.M. Zhou, and Y.H. Li Preliminary results of ifosfamide and doxorubicin regimen in treatment of patients with recurrent and metastatic nasopharyngeal carcinoma Ai Zheng 21 2002 409 411
38. K. Altundag, S. Aksoy, and I. Gullu Salvage ifosfamide-doxorubicin chemotherapy in patients with recurrent nasopharyngeal carcinoma pretreated with Cisplatin-based chemotherapy Med Oncol 21 2004 211 215 (Pubitemid 39469760)
39. C.C. Wang, J.Y. Chang, T.W. Liu, C.Y. Lin, Y.C. Yu, and R.L. Hong Phase II study of gemcitabine plus vinorelbine in the treatment of cisplatin-resistant nasopharyngeal carcinoma Head Neck 28 2006 74 80
40. L.L. Siu, P.M. Czaykowshi, and I.F. Tannock Phase I/II study of the CAPABLE regimen for patients with poorly differentiated carcinoma of the nasopharynx J Clin Oncol 16 1998 2514 2521 (Pubitemid 28309049)
41. H. Boussen, E. Cvitkovic, J.L. Wendling, M. Bachouchi, R. Mahjoubi, and C. Kalifa Chemotherapy of metastatic and/or recurrent undifferentiated nasopharyngeal carcinoma with cisplatin, bleomycin and uorouracil J Clin Oncol 9 1991 1675 1681
42. W.C. Su, T.Y. Chen, R.H. Kao, and C.J. Tsao Chemotherapy with cisplatin and continuous infusion of 5-fluorouracil and bleomycin for recurrent and metastatic nasopharyngeal carcinoma in Taiwan Oncology 50 1993 205 208
43. N. Azli, A. Fandi, and M. Bachouchi Final report of a phase II study of chemotherapy with bleomycin, epirubicin, and cisplatin for locally advanced and metastatic/recurrent undifferentiated carcinoma of the nasopharyngeal type Cancer J Sci Am 1 1995 222 229
44. A. Taamma, A. Fandi, and N. Azli Phase II trial combining mitomycin with 5-fluorouracil, epirubicin, and cisplatin in recurrent and metastatic undifferentiated carcinoma of nasopharyngeal type Ann Oncol 10 1999 421 425 (Pubitemid 29236419)
45. A. Hasbini, R. Mahjoubi, and A. Fandi Phase II trial combining mitomycin with 5-fluorouracil, epirubicin, and cisplatin in recurrent and metastatic undifferentiated carcinoma of nasopharyngeal type Ann Oncol 10 1999 421 425 (Pubitemid 29236419)
46. S.S. Leong, J. Wee, and S. Rajan Triplet combination of gemcitabine, paclitaxel, and carboplatin followed by maintenance 5-fluorouracil and folinic acid in patients with metastatic nasopharyngeal carcinoma Cancer 113 2008 1332 1337
47. H.Q. Huang, Q.Q. Cai, and X.B. Lin Preliminary result of multi-center clinical trial on the docetaxel, 5-Fu and DDP in the treatment of advanced, recurrent or metastatic nasopharyngeal carcinoma Zhonghua Zhong Liu Za Zhi 30 2008 314 316
48. A.T. Chan, V. Grégoire, and J.L. Lefebvre Nasopharyngeal cancer: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 21 Suppl 5 2010 v187 189
49. D.T. Chua, W.I. Wei, M.P. Wong, J.S. Sham, J. Nicholls, and G.K. Au Phase II study of gefitinib for the treatment of recurrent and metastatic nasopharyngeal carcinoma Head Neck 30 2008 863 867 (Pubitemid 352008945)
50. B. Ma, E.P. Hui, and A. King A phase II study of patients with metastatic or locoregionally recurrent nasopharyngeal carcinoma and evaluation of plasma Epstein-Barr virus DNA as a biomarker of efficacy Cancer Chemother Pharmacol 62 2008 59 64 [Epub 2007 Aug 29] (Pubitemid 351537846)
51. C. Elser, L.L. Siu, and E. Winquist Phase II trial of sorafenib in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or nasopharyngeal carcinoma J Clin Oncol 25 2007 3766 3773 PMID: 17704426 (Pubitemid 47372619)
52. A.T. Chan, M.M. Hsu, and B.C. Goh Phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma J Clin Oncol 23 2005 3568 3576
53. W.I. Wei, and J.S. Sham Nasopharyngeal carcinoma Lancet. 365 2005 2041 2054 (Pubitemid 40812341)
54. L.C. Cheng, J.S. Sham, C.S. Chiu, K.H. Fu, J.W. Lee, and C.K. Mok Surgical resection of pulmonary metastases from nasopharyngeal carcinoma Aust N Z J Surg 66 1996 71 73
55. Y. Zhao, H. Liao, X. Hou, J. Sun, Y. Guo, and S. Li A prospective, open-label, randomized phase II trial to evaluate the changes of bone resorption marker after administration of zoledronic acid (ZOL) in nasopharyngeal cancer (NPC) patients with bone metastases (BM) J Clin Oncol 27 15s 2009 [suppl; abstr 6063]